- TWD855.27m
- TWD980.90m
- TWD512.54m
- 37
- 14
- 41
- 16
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 972 | 900 | 977 | 521 | 513 |
Cost of Revenue | |||||
Gross Profit | 66.9 | 77.1 | 138 | 57.8 | 24 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,032 | 960 | 985 | 562 | 623 |
Operating Profit | -59.3 | -59.8 | -8.08 | -41 | -110 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -96.4 | -41.7 | -4.46 | -44.9 | -38.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -132 | -69.5 | -9.41 | -52.9 | -49.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -126 | -61 | 2.13 | -49.7 | -24.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -126 | -61 | 2.13 | -49.7 | -24.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.95 | -1.64 | 0.037 | -1.25 | -0.259 |
Dividends per Share |